The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Europe intravenous solutions market is currently witnessing moderate growth. Intravenous solutions refer to different kinds of fluids administered to a patient to provide salt, sugar and water through venous circulation. These solutions are a mix of several nutrients, like carbohydrates, vitamins, minerals, electrolytes, salt, and amino acid, which assist in fluid replacement in the body. Intravenous solutions may contain water with electrolytes, sugar or medications added in concentrations as per the patient’s need. In the European region, the increasing cases of gastrointestinal disorders, neurological diseases and cancer due to unhealthy eating habits and sedentary lifestyles have led to the rising need for intravenous solutions.
Europe represents one of the largest intravenous solution markets, primarily driven by the presence of prominent vendors. Moreover, the distribution networks for these products are well-established, which increases their availability. Besides this, the rising disposable incomes and significant expenditure on healthcare facilities are also contributing significantly to the market growth. Furthermore, the continual launch of new products to treat gastrointestinal diseases and dehydration has escalated the sales of intravenous solutions across the region, thus creating a positive outlook for the market. Looking forward, IMARC Group expects the market to continue its moderate growth during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe intravenous solutions market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, type and nutrients.
Breakup by Type:
Breakup by Nutrients:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at